James Kim, chairman of the American Chamber of Commerce in Korea (AMCHAM), is welcoming U.S. President Donald Trump’s announcement on Korea’s $54 billion (73.3 trillion won) investment in the Alaska liquefied natural gas (LNG) project, describing it a sign of progress in bilateral economic ties, but called for the two governments to resolve key commercial and legal details. “I see a shared interest in expanding energy cooperation, even if the two governments are emphasizing different aspects of the project,” Kim said in an interview with The Korea Times on Thursday. “A project of this scale requires careful consideration of investment costs, energy prices, commercial viability and participation terms,” he said, adding that questions surrounding the timing and coordination of the announcement are matters for the two governments to address. The contrasting positions have drawn attention because Washington presented the $54 billion figure as a Korean investment commitment, while Seoul has yet to determine details on the scale, structure or timing of any investment. From a busine

Hayfin Capital Management opened a new office in Seoul, Thursday, expanding its presence in the Asia-Pacific region following Samsung Life's investment in the firm as a strategic minority shareholder. Located at Three IFC in Yeouido, in Seoul's financial district, the office will provide on-the-ground coverage for Hayfin's growing base of Korean institutional investors and partners. "The Seoul office's focus is on understanding the needs of Korean institutional investors, connecting them effectively with the global team and enhancing the overall quality of client service," said Choi Si-jin, head of Korea at Hayfin. Choi, newly appointed to lead the office, has nearly two decades of experience in investment and institutional capital formation. He previously served as head of private equity for Asia-Pacific at UBS Asset Management and held senior roles at Wilshire Associates in Hong Kong, Samsung Life and Samsung Asset Management. The office opening follows Hayfin's management buyout, which closed in February 2025. Samsung Life, Mubadala and AXA IM Prime participated in the transaction as

Samsung Electronics Executive Chairman Lee Jae-yong joined global business leaders at a London gala celebrating a Korean art exhibition on Wednesday (local time), bringing cultural outreach and semiconductor partnerships together at the British Museum in the United Kingdom. About 240 political, business and cultural figures attended the dinner. Britain's Princess Anne attended a reception beforehand to mark the exhibition's opening. The exhibition, “Korea: 2,000 Years of Creativity,” explores 2,000 years of Korean creativity through works from the late Samsung Chairman Lee Kun-hee's collection. It is the museum's first major Korean art exhibition since 1984, according to Samsung. Jointly organized by the British Museum, the National Museum of Korea and the National Museum of Modern and Contemporary Art, Korea, it follows exhibitions in Washington and Chicago. London is the third overseas stop. Guests included ASML CEO Christophe Fouquet, Merck CEO Kai Beckmann, ZEISS CEO Andreas Pecher and Imec CEO Patrick Vandenameele, whose organizations cooperate with Samsung on semiconductor tech

Samsung Bioepis and Teva Pharmaceutical Industries have entered into an agreement on commercializing the former’s up to six potential biosimilar candidates, including two confirmed investigational candidates, the companies said Thursday. According to Samsung Bioepis, the two sides have signed a global licensing, development and commercialization agreement for the potential candidates. Of them, two confirmed investigational biosimilar candidates are SB41, referencing AstraZeneca’s Fasenra, a treatment primarily used for severe eosinophilic asthma, and SB44, referencing Novartis’ Ilaris, which treats a range of inflammatory conditions including rare autoinflammatory diseases. Under the terms of the agreement, Samsung Bioepis will be responsible for the development, regulatory registration and manufacturing of the biosimilars, while Teva will be responsible for commercialization in global markets, including the U.S., Europe and Canada. The companies have agreed to an option for expanding the partnership to other territories. Samsung Bioepis said the agreement reinforces their existing

GM Korea, the Korean unit of General Motors, said Thursday its sales surged 73.3 percent in September from a year earlier, driven by strong overseas demand. The company sold 41,101 vehicles last month, up from 23,723 units a year earlier, on robust sales of the Chevrolet Trax Crossover and the Trailblazer sport utility vehicle (SUV), GM Korea said in a press release. Domestic sales fell 40.9 percent to 727 units from 1,231, while exports jumped 79.5 percent to 40,374 from 22,492. From January to September, sales rose 17 percent to 381,785 units from 326,381 in the year-ago period. Domestic sales plunged 36.4 percent to 7,495 from 11,785 during the same period, while exports climbed 19 percent to 374,290 from 314,596. As part of its two-track strategy, GM Korea sells both locally assembled and imported vehicles in Korea, Asia's fourth-largest economy. Its current lineup consists of two locally assembled models — the Trailblazer and Trax Crossover — and one imported model, the GMC Sierra Denali. The Buick Electra E7 plug-in hybrid SUV is expected to be added to the lineup as early as next

The new Urban Cruiser is smaller, not just in size, but also in price.

GM Korea, the Korean unit of General Motors, said Thursday its sales surged 73.3 percent in September from a year earlier, driven by strong overseas demand. The company sold 41,101 vehicles last month, up from 23,723 units a year earlier, on robust sales of the Chevrolet Trax Crossover and the Trailblazer sport utility vehicle (SUV), GM Korea said in a press release. Domestic sales fell 40.9 percent to 727 units from 1,231, while exports jumped 79.5 percent to 40,374 from 22,492. From January to September, sales rose 17 percent to 381,785 units from 326,381 in the year-ago period. Domestic sales plunged 36.4 percent to 7,495 from 11,785 during the same period, while exports climbed 19 percent to 374,290 from 314,596. As part of its two-track strategy, GM Korea sells both locally assembled and imported vehicles in Korea, Asia's fourth-largest economy. Its current lineup consists of two locally assembled models — the Trailblazer and Trax Crossover — and one imported model, the GMC Sierra Denali. The Buick Electra E7 plug-in hybrid SUV is expected to be added to the lineup as early as next

Huawei Technologies is making rapid progress in rolling out a new breed of advanced chip based on its self-developed Tau Scaling Law, with the Chinese company set to adopt the processors across the newly released Mate 90 smartphone series. The roll-out marks another step forward in the Chinese tech giant’s push to overcome stringent US export curbs, which has seen Huawei rewire its smartphone business to run on home-grown technology. Speaking at a press briefing on Tuesday, Huawei consumer...

The new RS5 is the first Audi RS car to feature a hybrid powertrain.

Word on the street is that Apple could announce its new smart home hub on 13 October.